Post-stroke urinary incontinence
Conditions
Interventions
Intervention group:The experimental group implemented cudgel needle intervention on the basis of the routine treatment and rehabilitation of the control group. Each cudgel needle intervention lasted 3
Control group:1) Dietary care: Formulate an appropriate drinking plan. During the study period, the patients total daily water intake should be 1000 to 2000 milliliters. 2. Basic care: Based on the pa
Sponsors
Rehabilitation Department, Affiliated Hospital of Chengdu University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: (1) Patients in the recovery phase who meet both the diagnostic criteria for stroke according to traditional Chinese medicine (TCM) and Western medicine, as well as the diagnostic criteria for PSUI; (2) Patients with a Mini-Mental State Examination (MMSE) score greater than 21, indicating cognitive function sufficient to cooperate with treatment and examinations (see Appendix 1); (3) Patients with mild to moderate severity of urinary incontinence (ICIQ-SF score: 1-14 points); (4) Patients aged 18 years or older; (5) Patients without urinary tract infections and with normal results from urinalysis; (6) Patients who have not received urinary incontinence rehabilitation training or drug therapy within the past month; (7) Patients who voluntarily participate in this study and have signed the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Patients with urinary incontinence prior to stroke; 2. Patients with other conditions affecting urination or benign prostatic hyperplasia (BPH) with lower urinary tract symptoms; 3. Patients who have used sedatives or muscle relaxants during recent treatment (patients taking medications that affect urination during treatment); 4. Patients with severe primary diseases of the heart, liver, kidneys, or hematopoietic system; 5. Patients with skin damage in the treatment area, a history of fainting at needle insertion, or metal allergies; 6. Patients currently participating in other clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Classification of the severity of urinary incontinence; | — |
Secondary
| Measure | Time frame |
|---|---|
| International Consultation on Incontinence Questionnaire short form, ICI-Q-SF;Classification of the severity of urinary incontinence;Incontinence Quality of Life Questionnaire, I-QOL;Evaluation criteria for therapeutic effect; | — |
Countries
China
Contacts
Public ContactYinli Shen
Affiliated Hospital of Chengdu University of Traditional Chinese Medicine
Outcome results
None listed